Law360, New York (January 23, 2009) -- The news Friday that pharmaceutical bigwigs Pfizer Inc. and Wyeth Inc. are negotiating a buyout worth more than $60 billion sparked questions of how the Obama administration might respond to such a large proposal, particularly if it has to reconcile anti-competitive overlaps with serious economic troubles in the industry.
Pfizer has been in talks with rival Wyeth for several months about a takeover deal that would unite two of the biggest global drugmakers, the Wall Street Journal reported Friday,...
